Dr. Yasodha Natkunam, MD, PHD
Pleasanton, CA
24 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Natkunam, Anatomic Pathologist & Clinical Pathologist in Pleasanton, CA?
Dr. Yasodha Natkunam, MD, PHD is an Anatomic Pathologist & Clinical Pathologist, who primarily practices in Pleasanton, CA with 1 additional practice location. She has been practicing for over 24 years and is board certified by the American Board of Pathology. Dr. Natkunam graduated from Icahn School of Medicine at Mount Sinai and completed her residency at Stanford University Program. Dr. Natkunam is fluent in English and Tamil, and is currently seeing new patients. Dr. Natkunam’s practice accepts Kaiser Permanente, Medicaid, Medicare, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Natkunam’s office at (650) 723-7211.
Where did Dr. Natkunam go to medical school and complete their residency?
Residency: Stanford University Program
Medical School: Icahn School of Medicine at Mount Sinai
Is Dr. Natkunam board certified in Anatomic Pathologist & Clinical Pathologist?
Yes, Dr. Yasodha Natkunam, MD, PHD is board certified by the American Board of Pathology since 1998
What languages does Dr. Natkunam speak?
Dr. Natkunam and their clinical team can communicate with patients in the following languages:
English
Tamil
What conditions does Dr. Natkunam treat?
As a Anatomic Pathologist & Clinical Pathologist, Dr. Natkunam diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Natkunam. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Diffuse Large B-cell Lymphoma
- B-cell Lymphoma
- Non-Hodgkin Lymphoma
- Mantle Cell Lymphoma
- Lymphoma
- DLBCL
- Aggressive B-cell Lymphoma
- Diffuse B-cell Lymphoma
- B-cell Non-Hodgkin Lymphoma
- B-NHL
- Lymphatic Cancer
- B-cell Lymphosarcoma
- Lymphosarcoma
- NHL
- Large B-cell Lymphoma
- Lymphoma in Organs
- MCL
- Mantle Zone Lymphoma
- Intermediate Lymphoma
ICD-10 Codes:
- C8339: Diffuse large B-cell lymphoma, extranodal and solid organ sites
- C8330: Diffuse large B-cell lymphoma, unspecified site
- C8510: Unspecified B-cell lymphoma, unspecified site
- C83398: Diffuse large B-cell lymphoma of other extranodal and solid organ sites
- C8590: Non-Hodgkin lymphoma, unspecified, unspecified site
- C8331: Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck
- C8519: Unspecified B-cell lymphoma, extranodal and solid organ sites
- C8319: Mantle cell lymphoma, extranodal and solid organ sites
Also known as:
- Localized Swollen Lymph Nodes
- Widespread Swollen Lymph Nodes
- Swollen Lymph Nodes
- Enlarged glands in one area
- Local lymphadenopathy
- Swollen glands
- Generalized lymphadenopathy
- Multiple swollen glands
- Body-wide enlarged lymph nodes
- Lymphadenopathy
- Swollen Glands
- Enlarged Glands
ICD-10 Codes:
- R590: Localized enlarged lymph nodes
- R591: Generalized enlarged lymph nodes
- R599: Enlarged lymph nodes, unspecified
Also known as:
- Multiple Myeloma
- Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
- Active multiple myeloma
- Untreated multiple myeloma
- Plasma cell myeloma
ICD-10 Codes:
- C9000: Multiple myeloma not having achieved remission
Also known as:
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Chronic Lymphocytic Leukemia
- Acute Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia Treatment (PDQ®)
- AML Leukemia
- Acute Myeloblastic Leukemia
- Acute Myelogenous Leukemia
- ALL
- Acute lymphocytic leukemia
- Lymphoblastic leukemia
- CLL
- B-cell chronic lymphocytic leukemia
- Lymphocytic leukemia
ICD-10 Codes:
- C9200: Acute myeloblastic leukemia, not having achieved remission
- C9100: Acute lymphoblastic leukemia not having achieved remission
- C9110: Chronic lymphocytic leukemia of B-cell type not having achieved remission
Also known as:
- Blood Cell Tumor of Uncertain Behavior
- Blood and Bone Marrow Disorder
- Blood Disorder
- Bone Marrow Disease
- Lymphoid Tissue Tumor
- Hematopoietic Neoplasm
- Uncertain Blood Tumor
- Hematologic Conditions
- Diseases of Blood-Forming Organs
ICD-10 Codes:
- D479: Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified
- D47Z9: Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
- D7589: Other specified diseases of blood and blood-forming organs
Also known as:
- Myelodysplastic Syndrome
- Myelodysplastic Syndromes
- Myelodysplastic Syndromes Treatment (PDQ®)
- MDS
- Preleukemia
- Bone marrow failure disorder
ICD-10 Codes:
- D469: Myelodysplastic syndrome, unspecified
Also known as:
- Tumor of Uncertain Behavior
- Uncertain Neoplasm
- Growth of Unknown Nature
- Indeterminate Tumor
ICD-10 Codes:
- D487: Neoplasm of uncertain behavior of other specified sites
Which procedures does Dr. Natkunam perform as a Anatomic Pathologist & Clinical Pathologist?
As a Anatomic Pathologist & Clinical Pathologist, procedures performed by an Dr. Yasodha Natkunam may include:
- Ancillary Testing
- Blood Sample
- Blood Smear
- Blood Sugar / Plasma Glucose Test
- Bone Pathology
- Chemical Pathology Consultation
- Chemical Pathology Follow Up
- Electrolyte Test / PH Imbalance
For detailed information, please contact Dr. Natkunam's office.
Does Dr. Natkunam accept my insurance?
Dr. Natkunam accepts most major insurance plans. Important: Please call our office at (650) 723-7211 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Natkunam accept in Pleasanton, CA?
Dr. Natkunam in Pleasanton, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
AllCare Health Plan
Blue Shield of California
CVS Health (formerly Aetna)
Kaiser Permanente
Medicaid
Medicare
Santa Clara Family Health Plan
State of California
UnitedHealthcare
View All Insurances
Where is Dr. Natkunam's office located?
Dr. Yasodha Natkunam's Primary Practice
5555 W Las Positas Blvd
Pleasanton, CA 94588
(650) 723-7211
Recognitions
Publications
Germil centre protein HGAL promotes lymphoid hyperplasia
TURE COMMUNICATIONS, 2013
Bevacizumab and cyclosphosphamide, doxorubicin
Leukemia & lymphoma, 2014
Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte
Jourl of clinical oncology, 2014
LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with
HISTOPATHOLOGY, 2014
Expression of the Activating Receptor, NKp46 (CD335), in Human tural Killer and T-Cell Neoplasia.
American jourl of clinical pathology, 2013
Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal margil zone
AMERICAN JOURL OF HEMATOLOGY, 2013
LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas
BRITISH JOURL OF HAEMATOLOGY, 2013
CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma
BLOOD, 2013
Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades
Blood, 2013
Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma
Anls of diagnostic pathology, 2013
Usefulness of HGAL and LMO2 Immunohistochemistry in the Identification of Follicular Lymphomas of
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2013
Indolent T-Lymphoblastic Proliferation (iT-LBP)
ADVANCES IN ATOMIC PATHOLOGY, 2013
The spectrum of lymphoblastic, nodal and extranodal T-cell lymphomas
HUMAN PATHOLOGY, 2013
Syk-Induced Phosphatidylinositol
AMERICAN JOURL OF TRANSPLANTATION, 2013
Integration of Genomic Medicine into Pathology Residency Training The Stanford Open Curriculum
JOURL OF MOLECULAR DIAGNOSTICS, 2013
Selective Immunophenotyping for Diagnosis of B-cell Neoplasms
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2013
CD137 Ligand Is Expressed in Primary and Secondary Lymphoid Follicles and in B
AMERICAN JOURL OF SURGICAL PATHOLOGY, 2013
FHIT, EGFR, and MSH2
Applied immunohistochemistry & molecular morphology : AIMM / official
Follicular lymphoma in young adults: a clinicopathological and molecular study of 200 patients.
Modern pathology : an official jourl of the United States and Cadian A
TdT(+) T-lymphoblastic Populations Are Increased in Castleman Disease
AMERICAN JOURL OF SURGICAL PATHOLOGY, 2012
The contribution of HGAL
MODERN PATHOLOGY, 2012
Cyclin D3 coordites the cell cycle during differentiation to regulate erythrocyte size and number
GENES & DEVELOPMENT, 2012
CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T
AMERICAN JOURL OF PATHOLOGY, 2012
Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma
BLOOD, 2012
LIM domain only 2 protein expression, LMO2 germline genetic variation
LEUKEMIA & LYMPHOMA, 2012
IgG4-Related Systemic Sclerosing Disease of the Ocular Adnexa A Potential Mimic of Ocular Lymphoma
AMERICAN JOURL OF CLINICAL PATHOLOGY, 2012
The spectrum of B-cell lymphoma, unclassifiable
MODERN PATHOLOGY, 2012
Aggressive EBV-associated Lymphoproliferative Disorder
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012
Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue.
Pathologica, 2012
Lack of association of tumor
ANLS OF ONCOLOGY, 2012
Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population
Intertiol jourl of molecular epidemiology and genetics, 2011
Prediction of survival in diffuse large B
BLOOD, 2011
Clinicopathologic and Molecular Features of 122 Brazilian Cases of Nodal and Extranodal NK
AMERICAN JOURL OF SURGICAL PATHOLOGY, 2011
MicroRs Are Independent Predictors of Outcome in Diffuse Large B
CLINICAL CANCER RESEARCH, 2011
LMO2 protein expression predicts survival in patients with rheumatoid arthritis
LEUKEMIA & LYMPHOMA, 2011
HGAL Protein Expression Persists
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2011
The Efficacy of HGAL and LMO2 in the Separation of Lymphom
AMERICAN JOURL OF CLINICAL PATHOLOGY, 2011
T-cell lymphomas: a tale of heterogeneity masking clarity
LEUKEMIA & LYMPHOMA, 2011
Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte
HUMAN PATHOLOGY, 2010
Oral and Extraoral Plasmablastic Lymphoma Similarities and Differences
AMERICAN JOURL OF CLINICAL PATHOLOGY, 2010
Immunoarchitectural Patterns in Follicular Lymphoma
AMERICAN JOURL OF SURGICAL PATHOLOGY, 2010
Expression of LMO2 Is Associated With t(14;18)
AMERICAN JOURL OF CLINICAL PATHOLOGY, 2010
Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2010
Embryonic Stem Cell-Derived Endothelial Cells Engraft Into the Ischemic Hindlimb
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010
C-C Chemokine Receptor 1 Expression in Human Hematolymphoid Neoplasia
AMERICAN JOURL OF CLINICAL PATHOLOGY, 2010
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells
HAEMATOLOGICA-THE HEMATOLOGY JOURL, 2010
Characterization of D-cyclin proteins in hematolymphoid neoplasms
MODERN PATHOLOGY, 2010
PD-1 Expression in T-cell Lymphomas and Reactive Lymphoid Entities
AMERICAN JOURL OF SURGICAL PATHOLOGY, 2010
CD81 protein is expressed at high levels in normal germil center B cells
HUMAN PATHOLOGY, 2010
Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival
BRITISH JOURL OF HAEMATOLOGY, 2010
Building tissue microarrays from suspension cells.
Methods in molecular biology (Clifton, N.J.), 2010
Microtubule-associated Protein-2 is a Sensitive Marker of Primary and Metastatic Neuroblastoma
AMERICAN JOURL OF SURGICAL PATHOLOGY, 2009
Extracellular Sigl-Regulated Kise Positively Regulates the Oncogenic Activity of MCT
CANCER RESEARCH, 2009
Characterization of c
AMERICAN JOURL OF CLINICAL PATHOLOGY, 2009
Immunoarchitectural Patterns in Nodal Margil Zone B-Cell Lymphoma A Study of 51 Cases
AMERICAN JOURL OF CLINICAL PATHOLOGY, 2009
nofluidic proteomic assay for serial alysis of oncoprotein activation in clinical specimens
TURE MEDICINE, 2009
Low Stage Follicular Lymphoma
AMERICAN JOURL OF SURGICAL PATHOLOGY, 2009
Lack of Utility of CD20 Immunohistochemistry in Staging Bone Marrow Biopsies for Diffuse Large B
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2009
The Transcription Factor LMO2 Is a Robust Marker of Vascular Endothelium and Vascular Neoplasms
AMERICAN JOURL OF CLINICAL PATHOLOGY, 2009
Gray zones around diffuse large B cell lymphoma
Jourl of hematopathology, 2009
Human germil center-associated lymphoma protein expression is associated with improved failure
LEUKEMIA & LYMPHOMA, 2009
PTP1B is a negative regulator of interleukin 4-induced STAT6 sigling
BLOOD, 2008
Immunohistochemical characterization of sal-type extranodal NK
AMERICAN JOURL OF CLINICAL PATHOLOGY, 2008
Tissue microarrays from bone marrow aspirates for high
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2008
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with
BLOOD, 2008
Expression of HGAL in primary cutaneous large B-cell lymphomas
MODERN PATHOLOGY, 2008
Expression of the human germil-centre
BRITISH JOURL OF HAEMATOLOGY, 2008
LMO2 protein expression predicts survival in patients with diffuse large B
JOURL OF CLINICAL ONCOLOGY, 2008
Prognostic significance of VEGF, VEGF receptors
LABORATORY INVESTIGATION, 2008
The Stanford Tissue Microarray Database
NUCLEIC ACIDS RESEARCH, 2008
Selective loss of B-cell phenotype in lymphocyte predomint Hodgkin lymphoma
JOURL OF PATHOLOGY, 2007
The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignt neoplasms
MODERN PATHOLOGY, 2007
Intertiol standardized approach for flow cytometric residual disease monitoring in chronic
LEUKEMIA, 2007
Oncogenic regulators and substrates of the aphase promoting complex
AMERICAN JOURL OF PATHOLOGY, 2007
Mast cell tryptase and microphthalmia transcription factor effectively discrimite cutaneous mast
JOURL OF CUTANEOUS PATHOLOGY, 2007
Microvessel density and expression of vascular endothelial growth factor and its receptors
AMERICAN JOURL OF PATHOLOGY, 2007
The oncoprotein LMO2 is expressed in normal germil-center B cells and in human B-cell lymphomas
BLOOD, 2007
Expression of the R-binding protein VICKZ in normal hematopoietic tissues and neoplasms
HAEMATOLOGICA-THE HEMATOLOGY JOURL, 2007
Expression of the human germil center-associated lymphoma
BLOOD, 2007
The biology of the germil center.
Hematology / the Education Program of the American Society of Hematolo, 2007
Low CD27 expression in plasma cell dyscrasias correlates with high-risk disease
AMERICAN JOURL OF CLINICAL PATHOLOGY, 2006
EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis
JOURL OF IMMUNOLOGY, 2006
Jaw I/LRMP, a germil centre-associated marker for the immunohistological study of B-cell lymphomas
JOURL OF PATHOLOGY, 2006
Prognostic immunohistologic markers in human tumors: why are so few used in clinical practice?
LABORATORY INVESTIGATION, 2006
The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas
HAEMATOLOGICA-THE HEMATOLOGY JOURL, 2006
CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells
MODERN PATHOLOGY, 2006
Loss of CD19 expression in B-cell neoplasms
HISTOPATHOLOGY, 2006
Transmembrane adaptor molecules: a new category of lymphoid-cell markers
BLOOD, 2006
Utility of syndecan-1
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2005
Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2005
TMA-combiner, a simple software tool to permit alysis of replicate cores on tissue microarrays
MODERN PATHOLOGY, 2005
Cytologic diagnosis of Burkitt lymphoma.
Cancer, 2005
Treatment of verruca vulgaris with topical cidofovir in an immunlocompromised patient
TRANSPLANT INFECTIOUS DISEASE, 2005
Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine
CLINICAL CANCER RESEARCH, 2005
Expression of the human germil center-associated lymphoma (HGAL) protein
BLOOD, 2005
Expression pattern of intracellular leukocyte
LEUKEMIA, 2005
Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas
AMERICAN JOURL OF SURGICAL PATHOLOGY, 2005
Expression of the bcl-6 and MUM1
JOURL OF CUTANEOUS PATHOLOGY, 2005
A novel method for making tissue microarrays from small numbers of suspension cells
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2005
The NFATc1 transcription factor is widely expressed in white cells
BRITISH JOURL OF HAEMATOLOGY, 2005
Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells
BRITISH JOURL OF HAEMATOLOGY, 2004
Immunophenotypic and genotypic characterization of progression in follicular lymphomas
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2004
Intracellular siglling molecules as immunohistochemical markers of normal
BRITISH JOURL OF HAEMATOLOGY, 2004
Atypical cellular disorders.
Hematology / the Education Program of the American Society of Hematolo, 2004
Characterization of variant patterns of nodular lymphocyte predomint Hodgkin lymphoma with
AMERICAN JOURL OF SURGICAL PATHOLOGY, 2003
Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report
ANLS OF HEMATOLOGY, 2003
Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100
MODERN PATHOLOGY
What is Dr. Natkunam's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Natkunam's National Provider Identifier (NPI) number is 1033261151.
What common questions do patients ask about Dr. Natkunam?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Natkunam
What is Dr. Yasodha Natkunam's specialty?
Dr. Natkunam is a Anatomic Pathologist & Clinical Pathologist near Pleasanton, CA. A pathologist focuses on the causes and nature of diseases, contributing to diagnosis, prognosis, and treatment by applying knowledge from biological, chemical, and physical sciences in the laboratory. They utilize microscopic examinations of tissue specimens, cells, and body fluids, along with clinical laboratory tests on fluids and secretions, to diagnose, exclude, or monitor diseases. Contact Dr. Natkunam to book an appointment today.
Is this Dr. Yasodha Natkunam affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Natkunam is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Anatomic Pathologist & Clinical Pathologist?
Explore Anatomic Pathologist & Clinical Pathologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Yasodha Natkunam accepting new patients in Pleasanton, CA?
Yes, Dr. Yasodha Natkunam is accepting new patients at this time.
Does Dr. Yasodha Natkunam offer online booking?
Please contact Dr. Natkunam's office at (650) 723-7211 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Yasodha Natkunam?
Please contact Dr. Natkunam's office at (650) 723-7211 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Yasodha Natkunam have?
Dr. Yasodha Natkunam is certified by the American Board of Pathology.
Other Anatomic Pathologist & Clinical Pathologist Near Pleasanton, CA
Anatomic Pathologist & Clinical Pathologist
Accepting patientsAnatomic Pathologist & Clinical Pathologist
Accepting patientsAnatomic Pathologist & Clinical Pathologist
Accepting patients